Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2017

01-12-2017 | Images

Diagnostic Dilemma in the Morphological Detection of Flower Cells in Lymphomas

Authors: Neha Singh, Jatin Gandhi, Narendra Agrawal, Ajit Panaych, Narender Tejwani, Anurag Mehta

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2017

Login to get access

Abstract

“Flower cells” are described typically in HTLV-1 induced adult T cell leukemia. Very few case reports have been published documenting flower cells in B cell lymphomas. We herein present a case of Burkitt lymphoma proven on the basis of immunophenotyping and FISH studies, with “flower cells” morphology.
Literature
1.
2.
go back to reference Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951CrossRefPubMed Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951CrossRefPubMed
3.
go back to reference Wong E, Juneja S (2014) Diffuse large B-cell lymphoma in leukemic phase with flower cell morphology. Blood 123(22):3378CrossRefPubMed Wong E, Juneja S (2014) Diffuse large B-cell lymphoma in leukemic phase with flower cell morphology. Blood 123(22):3378CrossRefPubMed
5.
go back to reference Thomas DA, O’Brien S, Faderl S et al (2011) Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: Should these be treated as different diseases? Curr Hematol Malig Rep 6(1):58–66CrossRefPubMedPubMedCentral Thomas DA, O’Brien S, Faderl S et al (2011) Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: Should these be treated as different diseases? Curr Hematol Malig Rep 6(1):58–66CrossRefPubMedPubMedCentral
Metadata
Title
Diagnostic Dilemma in the Morphological Detection of Flower Cells in Lymphomas
Authors
Neha Singh
Jatin Gandhi
Narendra Agrawal
Ajit Panaych
Narender Tejwani
Anurag Mehta
Publication date
01-12-2017
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2017
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0782-3

Other articles of this Issue 4/2017

Indian Journal of Hematology and Blood Transfusion 4/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine